UNITED STATES 

SECURITIES AND EXCHANGE COMMISSION 

Washington, D.C. 20549 

 

 

FORM 15 

 

 

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION 

UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 

OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) 

OF THE SECURITIES EXCHANGE ACT OF 1934

 

Commission File Number 001-39328 

 

 

Genetron Holdings Limited

(Exact name of registrant as specified in its charter) 

 

 

1-2/F, Building 11, Zone 1, 

No.8 Life Science Parkway 

Changping District, Beijing, 102206 

People’s Republic of China 

+86 10 5090-7500

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

 

Ordinary Shares, par value US$0.0001 per share 

American depositary shares, each representing fifteen (15) Ordinary Shares 

(Title of each class of securities covered by this Form)

 

None 

(Titles of all other classes of securities for which a duty to file reports under Section 13(a) or 15(d) remains) 

 

 

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

 

Rule 12g-4(a)(1)	x
Rule 12g-4(a)(2)	¨
Rule 12h-3(b)(1)(i)	x
Rule 12h-3(b)(1)(ii)	¨
Rule 15d-6	¨

 

Approximate number of holders of record as of the certification or notice date: one

 

 

 

Pursuant to the requirements of the Securities Exchange Act of 1934, Genetron Holdings Limited has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

 

Date: April 8, 2024	GENETRON HOLDINGS LIMITED
	By:	/s/ Sizhen Wang
		Name:	Sizhen Wang
		Title:	Chief Executive Officer